Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Miriam Frech
Observed names:
Dr. Miriam Frech,
Frech, Miriam,
M Frech,
M. Frech
Institution:
Philipps University of Marburg
Observed institutions:
Philipps University of Marburg,
Universitätsklinikum Gießen und Marburg,
Technische Universität Darmstadt
ORCID:
0009-0008-7684-2550
Observed ORCID:
0009-0008-7684-2550
OpenAlex ID:
A5010964600
Immunosuppressive capacity of mesenchymal stem cells correlates with metabolic activity and can be enhanced by valproic acid
2017
·
Madeleine C. Killer
, Philipp Nold
, et al.
·
Stem Cell Research & Therapy
·
56
PDF
IRF8 Is an AML-Specific Susceptibility Factor That Regulates Signaling Pathways and Proliferation of AML Cells
2021
·
Franziska Liss
, Miriam Frech
, et al.
·
Cancers
·
26
PDF
KLF4-mediated upregulation of the NKG2D ligand MICA in acute myeloid leukemia: a novel therapeutic target identified by enChIP
2023
·
Reem Alkhayer
, Viviane Ponath
, et al.
·
Cell Communication and Signaling
·
25
PDF
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1
2018
·
Christine Feld
, Peeyush Sahu
, et al.
·
Nucleic Acids Research
·
20
PDF
Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient with RCSD1-ABL1 -positive acute lymphoblastic leukemia
2017
·
Miriam Frech
, Lutz B. Jehn
, et al.
·
Haematologica
·
19
PDF
Direct interaction of PU.1 with oncogenic transcription factors reduces its serine phosphorylation and promoter binding
2011
·
A Seshire
, T Rößiger
, et al.
·
Leukemia
·
17
The Oncoprotein SKI Acts as A Suppressor of NK Cell-Mediated Immunosurveillance in PDAC
2020
·
Viviane Ponath
, Miriam Frech
, et al.
·
Cancers
·
15
PDF
IRF2BP2 counteracts the ATF7/JDP2 AP-1 heterodimer to prevent inflammatory overactivation in acute myeloid leukemia (AML) cells
2024
·
Sabrina Fischer
, Lisa Marie Weber
, et al.
·
Nucleic Acids Research
·
11
Glucose inhibits the formation of gas vesicles in Haloferax volcanii transformants
2007
·
Torsten Hechler
, Miriam Frech
, et al.
·
Environmental Microbiology
·
11
A Bioinformatics View on Acute Myeloid Leukemia Surface Molecules by Combined Bayesian and ABC Analysis
2022
·
Michael C. Thrun
, Elisabeth K. M. Mack
, et al.
·
Bioengineering
·
8
PDF
MYB induces the expression of the oncogenic corepressor SKI in acute myeloid leukemia
2018
·
Miriam Frech
, Sabine Teichler
, et al.
·
Oncotarget
·
5
PDF
Genetic engineering of primary human mesenchymal stromal cells using the CRISPR/Cas9 synergistic activation mediator
2026
·
M.C. Killer
, X. Zhang
, et al.
·
Genes & Diseases
·
1
The Oncoprotein SKI As a Driver in KMT2A-MLLT3/NRasG12D-Positive Acute Myeloid Leukemia
2023
·
Miriam Frech
, Janine Schaprian
, et al.
·
Blood
·
1
The Genes for Tissue Factor F3 and Nuclear Receptor 4A Are Down-Regulated in Early Death Acute Promyelocytic Leukemia Patients
2018
·
Miriam Frech
, Kathleen Stabla
, et al.
·
Blood
·
1
Identification of the Oncogene SKI As a New Target Gene of the Myeloid Transcription Factor c-MYB in AML
2016
·
Miriam Frech
, Sabine Teichler
, et al.
·
Blood
·
1
Additional file 1: Figure S1. of Immunosuppressive capacity of mesenchymal stem cells correlates with metabolic activity and can be enhanced by valproic acid
2017
·
Killer, Madeleine
, Nold, Philipp
, et al.
·
Figshare
Interaktionspartner von PLZF/RARalpha und ihr Einfluss auf die Entwicklung akuter Promyelozytenleukämie
2014
·
Frech, Miriam
·
open_UMR Marburg DSpace 10.0 (Philipps-Universität Marburg)
Show more works
View as search
Works count:
21
Citation count:
217
H-index:
9
I10-index:
9
Year
Topic
Type